A Phase 2, Open-Label Study to Evaluate the Safety and Effects of HLX-1502 in Patients With Neurofibromatosis Type 1

ClinicalTrials.gov ID: NCT06541847

Public ClinicalTrials.gov record NCT06541847. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced May 20, 2026, 2:38 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Open-Label, Single Arm, Non-Controlled, Single-Stage Study to Evaluate the Safety and Effects of HLX-1502 in Patients With Plexiform Neurofibroma and Neurofibromatosis Type 1

Study identification

NCT ID: NCT06541847
Recruitment status: Recruiting
Study type: Interventional
Phase: Phase 2
Lead sponsor: Healx Limited; Industry
Enrollment: 25 participants

Conditions and interventions

Conditions

Neurofibromatosis Type 1

Interventions

HLX-1502 Drug

Drug

Eligibility (public fields only)

Age range: 12 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Feb 9, 2025
Primary completion: May 31, 2027
Completion: Dec 31, 2027
Last update posted: May 18, 2026

2025 – 2028

United States locations

U.S. sites: 14
U.S. states: 12
U.S. cities: 13

Facility	City	State	ZIP	Site status
University of Alabama at Birmingham	Birmingham	Alabama	35294	Recruiting
Children's Hospital Los Angeles	Los Angeles	California	90027	Recruiting
Stanford University	Palo Alto	California	94304	Recruiting
Children's Hospital Colorado	Aurora	Colorado	80045	Recruiting
Children's National Hospital	Washington D.C.	District of Columbia	20010	Recruiting
Ann & Robert H. Lurie Children's Hospital of Chicago	Chicago	Illinois	60611	Recruiting
University of Chicago	Chicago	Illinois	60637	Recruiting
Indiana University	Indianapolis	Indiana	46202	Recruiting
Johns Hopkins Hospital	Baltimore	Maryland	21287	Recruiting
Washington University School of Medicine	St Louis	Missouri	63110	Recruiting
New York University Langone Health	New York	New York	10016	Recruiting
Cincinnati Children's Hospital Medical Center	Cincinnati	Ohio	45229	Recruiting
Children's Hospital of Philadelphia	Philadelphia	Pennsylvania	19104	Recruiting
University of Texas Southwestern Medical Center	Dallas	Texas	75390	Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT06541847, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted May 18, 2026 · Synced May 20, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06541847 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →